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asthma. METHODS: IHCIS managed care benchmark database
representing over 40 million US commercial lives was analyzed.
The ﬁrst prescription claim for an ICS in 2005 was identiﬁed
(index date) and patients who were continuously eligible for
medical and pharmacy services for 12 month before and after
the index date were included. Patients were selected based on the
following criteria using the 12 month pre-index date: 1) asthma-
related ER use or hospitalization >= 1, 2) asthma-related MD
visits >= 4, or 3) asthma-related medication ﬁlls >= 4 and diag-
nosis of asthma >= 1. Adherence was measured using both med-
ication possession ratio—MPR (adherence) and having at least
one ICS claim for each of the four post-index quarters (persis-
tence). Health care utilization including ER visits and hospital-
izations during the post 12 month period was compared between
the adherent and non-adherent groups. Poisson regression was
utilized to evaluate the impact of adherence with ICS on utiliza-
tion controlling for potential confounding factors. RESULTS: A
total of 18,420 patients 55.8% female with an average age of
31.68 met the criteria for ﬁnal analyses. Mean MPR was 0.43
and 12.7% of the study population had MPR >= 0.8 (adherent).
44.7% of patients ﬁlled at least one ICS prescription for four
consecutive quarters (persistent). Compared to non-adherent
patients, adherent patients had signiﬁcantly less incidence of hos-
pitalization or ER visit (IRR, 0.58; 95% CI, 0.37–0.89). Simi-
larly, persistence with ICS prescription ﬁlling behavior was
associated with a signiﬁcantly lower incidence of hospitalization
or ER visit (IRR, 0.74; 95% CI, 0.62–0.87). CONCLUSION:
Adherence with ICS was suboptimal in selected patients with
asthma. Regardless of metric used, patients identiﬁed as adher-
ent were less likely to have an asthma-related hospitalization or
ER visit.
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IS CURE WORSE THAN THE DISEASE?
Baser O
Thomson Medstat, Ann Arbor, MI, USA
OBJECTIVES: Instrumental variable approach gained popular-
ity in outcomes research because even in the presence of unmea-
sured confounding, such methods may consistently estimate the
average causal effects. However, for this consistent estimation to
be achieved several conditions must hold. Recent outcomes
research literature seems to ignore these conditions and the
results may provide inconsistent estimates. In this paper, we will
overview insturumental variable approach, as well as possible
tests to check the pre-requisite conditions and show how weak
instruments may produce inconsistents and inefﬁcient results.
METHODS: Recently proposed Swanson and Chao tests used
to check for weak instruments. For the cases with single endoge-
nous variables conditional likelihood ratio is implemented and
used. For the cases with more than one endogenous regressor
Anderson Rubin test is reviewed. Relevant level curve presented
for two endogeneous variables. RESULTS: The Market Scan
private insurance data base was used in this study which based
upon analytic sample of 36,341 asthma individuals whose health
care was provided under a variety of fee-for-service (FFS), fully
capitated and partially capitated health plans , including exclu-
sive provider organizations, indemnity plans. We showed how to
test weak insturements under the assumption that we have single
endogenous variables. We showed that one of the insturement
was weaked and the results produced inconsistent and inefﬁcient
estimates of the effect of treatment. With the correct instruments,
the estimates were statistically signiﬁcant (p = 0.001). CON-
CLUSION: Despite the obvious beneﬁt of instrumental variable
models, the method should not be used blindly. Several strong
conditions required for these models to work, and each of them
should be tested. Otherwise the results would be statatistically
worse than the results that can be achieved using simple ordi-
nary least squares.
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OBJECTIVES: The ability of asthma patients to feel their main-
tenance inhaler work right away and their satisfaction with this
perception could serve as positive reinforcement of daily inhaler
therapy, leading to higher levels of persistence and improved
health status. This study examined the reliability and validity of
a 5-item weekly diary, the “Onset of Effect Questionnaire”
(OEQ), for describing patient perceptions associated with feeling
a maintenance therapy working right away as an initial step in
understanding this phenomenon. METHODS: Secondary analy-
ses of data from 360 patients (aged >18 yrs) with mild to mod-
erate asthma gathered during a Phase III, 12-week, randomized,
double-blind, double-dummy, placebo-controlled clinical trial
(SD-039-0716) comparing budesonide/formoterol pMDI with its
monoproducts. OEQ items were analyzed using dichotomous
scaling; the items identifying patients who perceived their med-
ication working right away (perception) and patients satisﬁed
with this perception (satisfaction) at Week1 were pre-speciﬁed as
primary outcomes. Statistical tests of reproducibility and valid-
ity were based on a comprehensive, a priori analysis plan.
RESULTS: One-week reproducibility: perception: phi = 0.77;
satisfaction: 0.70 (p < 0.0001). Construct validity: both perceiv-
ing and satisﬁed patients exhibited a higher increase in FEV1 15
minutes post-baseline than those who were not (p < 0.0001).
Those perceiving and satisﬁed patients also reported higher
symptom severity scores (Asthma Quality of Life Questionnaire)
than those who were not (p < 0.05; p < 0.01), with no differ-
ence in rescue medication use. Predictive: Patients perceiving and
those satisﬁed at Week 1 had higher 15 minute post-dose FEV1
(p < 0.0001) and greater satisfaction with medication (Overall
Perception of Medication subscale of the Patient Satisfaction
with Asthma Medication (PSAM) questionnaire) and asthma
relief (PSAM Relief subscale) at the end of Week 2 than patients
who did not (p < 0.0001). CONCLUSION: The weekly diary
approach is a reliable and valid method for identifying patients
who perceive their medication working right away and those sat-
isﬁed with this perception.
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OBJECTIVES: The inﬂuence of positive reinforcement on behav-
ior is well documented, beginning with the original work by B.F.
Skinner to more recent evidence showing its value in improving
treatment adherence. An important challenge in the asthma pop-
ulation is persistence with daily maintenance therapy. Immedi-
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ate, positive reinforcement with a maintenance inhaler has the
potential for increasing satisfaction and persistence with treat-
ment and improving health status. METHODS: Two qualitative
studies using structured interviews were conducted to under-
stand patient perceptions associated with feeling an asthma 
medication working right away and develop a method for 
quantifying this perception in clinical trials. RESULTS: Study I:
56 asthma patients (44 yrs, SD = 18) were asked about the
concept of feeling their medication working right away and
whether it was important. Respondents described the perception
as breathing easier and deeper and felt this would be meaning-
ful and reassuring. Five items, labeled the “Onset of Effect Ques-
tionnaire” (OEQ), were developed for use as a weekly diary.
Items to identify patients who perceived their medication
working right away and those satisﬁed with the perception were
of particular interest. Items were pre-tested via telephone inter-
view (n = 11) and found to be clear, comprehensive, and easy to
complete. Patients understood the concept and the concise,
weekly diary approach. Study II: 39 asthma patients (37 years,
SD = 15) participated in cognitive debrieﬁng interviews to test
item interpretation and gather additional data on perception and
its value. Respondents characterized the items as clear, inter-
preted “right away” as immediately to <15 minutes after inhala-
tion, and had no difﬁculty interpreting the 1-week recall.
CONCLUSION: Patients understand and value the concept of
perceiving a maintenance therapy working right away. A concise,
weekly recall diary approach can be used to quantify this
attribute in clinical trials.
ALLERGY/ASTHMA—Patient-Reported Outcomes
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OBJECTIVES: To determine the relationship between Health-
Related Quality of Life (HRQL) and asthma control in children
as deﬁned by the Canadian Pediatric Asthma Consensus Guide-
lines (CPACG). METHODS: Cross-sectional data on 879 chil-
dren aged 1 to 18 from a completed study of children with a
diagnosis of asthma were analyzed. The Pediatric Asthma
Quality of Life Questionnaire (PAQLQ) was administered by
interview and information regarding the following asthma
control parameters was collected: daytime symptoms, night-time
symptoms, beta2-agonist use, physical activity level, exacerba-
tions, and school absences. The Pearson correlation was calcu-
lated between the asthma control parameters satisﬁed and the
PAQLQ domain scores. The level of agreement between the top
quintile of each PAQLQ domain (≥80th percentile) and accept-
able asthma control (all six parameters satisﬁed) was evaluated
using the kappa statistic to measure agreement beyond chance.
This was also done for unacceptable control (four or fewer out
of six parameters satisﬁed) and the bottom quintile PAQLQ
scores. RESULTS: The correlations between the number of
asthma control parameters and the PAQLQ domains were 0.507,
0.467, and 0.474, (p < 0.0001) for the symptoms, activity limi-
tations, and emotional function domains respectively. The kappa
for the top quintile of each PAQLQ domain and acceptable
control was 0.206 for symptoms, 0.117 for activity limitations,
and 0.184 for emotional function. The level of agreement
between unacceptable control for the lowest quintiles domains
was 0.128, 0.114, and 0.133 for symptoms, activity, and emo-
tional function, respectively. CONCLUSION: The strong rela-
tionship between asthma control and HRQL supports a shared
focus on control and quality of life in the CPACG. The low level
of agreement between the control levels and the PAQLQ quin-
tiles suggests further study is needed to determine optimal cut-
offs for control levels and the marginal beneﬁts from quality of
life measures.
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OBJECTIVES: Patients with allergic rhinitis (AR) experience a
multitude of symptoms that usually compromise some aspect of
lifestyle and work productivity. METHODS: A questionnaire
was developed and mailed to 2065 patients enrolled in a 500,000
member managed care organization. Patients were identiﬁed by
diagnostic codes for AR as determined from a retro-examination
of medical and prescription claims records from January 1, 2000
to December 31, 2000. A ten-point scale was used to assess the
impact of allergy symptoms on work productivity adapted from
the Allergy-Speciﬁc Work Productivity and Activity Impairment
questionnaire. RESULTS: On average respondents (n = 577)
reported one hour of work missed per week because of allergy
symptoms (range = 0–32 hours). For patients seeing family physi-
cians, 66 (55.0%) reported that either a blood or skin test was
valuable during the process of allergy diagnosis, 82 (73.9%) for
allergists, and 56 (65.1%) for self-managed patients who were
previously tested. Chi-square and analysis of variance tests also
revealed signiﬁcant differences among three care groups (p <
0.05) for years with allergies, symptoms, family history, testing,
immunotherapy, test value, and prescribed antihistamine use.
Multiple linear regression analysis revealed that sleep, health-
related quality of life (HRQoL), certain allergy symptoms and
prescribed antihistamines were signiﬁcantly related to work pro-
ductivity. CONCLUSION: The ability of individuals with AR to
engage in productive work is inﬂuenced by sleep, HRQoL, spe-
ciﬁc symptoms, and prescribed antihistamine use. Appropriate
clinical evaluation and an accurate diagnosis using either or both
speciﬁc IgE testing or skin testing is needed to develop a holistic
approach for treatment.
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OBJECTIVES: To determine the socioeconomic predictors of
asthma control in children, as deﬁned by the Canadian Pediatric
Asthma Consensus Guidelines (CPACG). METHODS: A cross-
sectional design was used to analyze data from a completed
CIHR-funded study based on 879 children from seven sites in
the Greater Toronto Area between 2000–2003. Children were
aged 1 to 18 years with a documented diagnosis of asthma and
a prescription for an asthma medication in the previous year.
Multiple linear regressions were used to analyze asthma control
based on six equally weighted control parameters (daytime
symptoms, night-time symptoms, need for beta2-agonists, phys-
